Annual CFI
$102.89 M
+$173.46 M+245.78%
December 31, 2023
Summary
- As of February 7, 2025, EWTX annual cash flow from investing activities is $102.89 million, with the most recent change of +$173.46 million (+245.78%) on December 31, 2023.
- During the last 3 years, EWTX annual CFI has risen by +$127.27 million (+521.99%).
- EWTX annual CFI is now at all-time high.
Performance
EWTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$25.36 M
-$12.01 M-32.13%
September 30, 2024
Summary
- As of February 7, 2025, EWTX quarterly cash flow from investing activities is $25.36 million, with the most recent change of -$12.01 million (-32.13%) on September 30, 2024.
- Over the past year, EWTX quarterly CFI has increased by +$1.94 million (+8.30%).
- EWTX quarterly CFI is now -48.29% below its all-time high of $49.04 million, reached on March 31, 2023.
Performance
EWTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$178.59 M
+$1.94 M+1.08%
September 30, 2024
Summary
- As of February 7, 2025, EWTX TTM cash flow from investing activities is -$178.59 million, with the most recent change of +$1.94 million (+1.08%) on September 30, 2024.
- Over the past year, EWTX TTM CFI has dropped by -$178.90 million (-58274.27%).
- EWTX TTM CFI is now -273.59% below its all-time high of $102.89 million, reached on December 31, 2023.
Performance
EWTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
EWTX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +245.8% | +8.3% | -10000.0% |
| 3 y3 years | +522.0% | +8.3% | -10000.0% |
| 5 y5 years | +10000.0% | +8.3% | -10000.0% |
EWTX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +142.5% | -48.3% | +109.5% | -273.6% | +26.3% |
| 5 y | 5-year | at high | +142.5% | -48.3% | +109.5% | -273.6% | +36.3% |
| alltime | all time | at high | +142.5% | -48.3% | +109.5% | -273.6% | +36.3% |
Edgewise Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $25.36 M(-32.1%) | -$178.59 M(-1.1%) |
| Jun 2024 | - | $37.37 M(-113.9%) | -$180.54 M(-15.8%) |
| Mar 2024 | - | -$268.31 M(-1094.4%) | -$214.46 M(-308.4%) |
| Dec 2023 | $102.89 M(-245.8%) | $26.98 M(+15.2%) | $102.89 M(>+9900.0%) |
| Sep 2023 | - | $23.42 M(+580.4%) | $307.00 K(-100.6%) |
| Jun 2023 | - | $3.44 M(-93.0%) | -$49.43 M(-6.6%) |
| Mar 2023 | - | $49.04 M(-164.9%) | -$52.92 M(-25.0%) |
| Dec 2022 | -$70.58 M | -$75.60 M(+187.2%) | -$70.58 M(-468.7%) |
| Sep 2022 | - | -$26.32 M(>+9900.0%) | $19.14 M(+38.2%) |
| Jun 2022 | - | -$46.00 K(-100.1%) | $13.85 M(-109.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $31.39 M(+122.3%) | -$146.07 M(-39.7%) |
| Dec 2021 | -$242.23 M(+893.5%) | $14.12 M(-144.7%) | -$242.23 M(-13.7%) |
| Sep 2021 | - | -$31.61 M(-80.2%) | -$280.53 M(+12.7%) |
| Jun 2021 | - | -$159.97 M(+147.0%) | -$248.92 M(+179.2%) |
| Mar 2021 | - | -$64.77 M(+167.9%) | -$89.14 M(+265.6%) |
| Dec 2020 | -$24.38 M(>+9900.0%) | -$24.18 M(>+9900.0%) | -$24.38 M(>+9900.0%) |
| Sep 2020 | - | -$6000.00(-96.8%) | -$203.00 K(+3.0%) |
| Jun 2020 | - | -$188.00 K(+1988.9%) | -$197.00 K(+2088.9%) |
| Mar 2020 | - | -$9000.00 | -$9000.00 |
| Dec 2019 | -$180.00 K | - | - |
FAQ
- What is Edgewise Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual CFI year-on-year change?
- What is Edgewise Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly CFI year-on-year change?
- What is Edgewise Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Edgewise Therapeutics?
- What is Edgewise Therapeutics TTM CFI year-on-year change?
What is Edgewise Therapeutics annual cash flow from investing activities?
The current annual CFI of EWTX is $102.89 M
What is the all time high annual CFI for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual cash flow from investing activities is $102.89 M
What is Edgewise Therapeutics annual CFI year-on-year change?
Over the past year, EWTX annual cash flow from investing activities has changed by +$173.46 M (+245.78%)
What is Edgewise Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of EWTX is $25.36 M
What is the all time high quarterly CFI for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly cash flow from investing activities is $49.04 M
What is Edgewise Therapeutics quarterly CFI year-on-year change?
Over the past year, EWTX quarterly cash flow from investing activities has changed by +$1.94 M (+8.30%)
What is Edgewise Therapeutics TTM cash flow from investing activities?
The current TTM CFI of EWTX is -$178.59 M
What is the all time high TTM CFI for Edgewise Therapeutics?
Edgewise Therapeutics all-time high TTM cash flow from investing activities is $102.89 M
What is Edgewise Therapeutics TTM CFI year-on-year change?
Over the past year, EWTX TTM cash flow from investing activities has changed by -$178.90 M (-58274.27%)